Health Care & Life Sciences » Pharmaceuticals | Formosa Laboratories Inc.

Formosa Laboratories Inc. | Mutual Funds

Mutual Funds that own Formosa Laboratories Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Core Equity Portfolio
825,604
0.85%
57,168
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
659,939
0.68%
38,112
0.01%
01/31/2018
Dah Fa Fund
322,476
0.33%
21,593
2.38%
03/31/2018
WisdomTree Emerging Markets Small Cap Dividend Fund
281,594
0.28%
0
0.03%
09/06/2018
DFA Dimensional Emerging Markets Value Fund
278,819
0.28%
110,324
0%
01/31/2018
Royce Value Trust
275,810
0.28%
0
0.03%
06/30/2018
Deutsche Far Eastern DWS Taiwan Flagship Invt. Trust Fund
206,586
0.21%
983
2.76%
03/31/2018
RSIT Digital Fund (The)
120,928
0.12%
575
1.44%
03/31/2018
WisdomTree Emerging Markets Equity Income Fund
116,370
0.12%
0
0.01%
09/06/2018
105,812
0.11%
5,518
2.88%
03/31/2018

About Formosa Laboratories

View Profile
Address
No. 36 Hoping Street
Taoyuan 338 42
Taiwan
Employees -
Website http://www.formosalab.com
Updated 07/08/2019
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. It specializes in development, production, process, and sale of ultraviolet absorbers, cholesterol phosphate binders, vitamin D derivatives, anti-inflammatory analgesic, and central nervous system drugs. The company's products include active pharmaceutical ingredients, contract research and custom synthesis, integrated application delivery controller services, and ultraviolet filters for sunscreens and cosmetics.